Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan Long-term Safety in Erosive Esophagitis
NCT02679508Phase 4Completed
- Sponsor
- Takeda
- Start
- Mar 2016
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vonoprazan in erosive esophagitis (EE), sponsored by Takeda. Started Mar 2016; status: completed.
02
Drugs
vonoprazan
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT02679508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02679508.